CALL: (0044) 7735-033068 [UK Labs]
One of the major causes of concern with viruses is that they do not remain the same but they evolve over time significantly. After effective vaccines have been produced for one strain of a virus, this does not mean that this vaccine will be equally effective against new variants of the virus. Scientists are currently trying to determine how effective the COVID-19 vaccines are against emerging variants. Vaccine effectivity against the Alpha and Delta variants of SARS-CoV-2 has already been under substantial investigation.
Like any organic forms, viruses evolve. The changes that take place - often called mutations - can bring about versions of a virus that are significantly different from the first version detected.
A variant of a virus that exhibits qualities making it more dangerous to humans, it is called a 'Variant of Concern', which the CDC describes as: "A variant for which there is evidence of an increase in transmissibility, more severe disease (e.g., increased hospitalizations or deaths), significant reduction in neutralization by antibodies generated during previous infection or vaccination, reduced effectiveness of treatments or vaccines, or diagnostic detection failures."
Obviously, it is a health concern of grave concern when a virus such as SARS-CoV-2 mutates into a more dangerous variant. For example, the Delta Variant of SARS-CoV-2 is of particular concern as it is almost 100% more contagious than the original strain, identified in 2019, and it appears to be infecting fully vaccinated individuals and causing equally aggressive illness in them.
The global scientific and medical community are observing to what degree the new variants of SARS-CoV-2 respond to vaccination. In the graph above it can be seen that the efficacy of three different vaccines against symptomatic infection by the Alpha and Delta variants has been almost universally lower. However, it is vital to mention that additional data confirms that in the case of those three vaccines the efficacy levels against hospital admission has increased, which means that some vaccines can remain just as effective against variants.
What has been sufficiently established through COVID-19 research already undertaken, is that the 'nutritional status' of the person who has been infected - the level of key nutrients in their body - is one of the core factors determining disease progression. The level of certain vitamins, minerals and other micronutrients in someone's body is a deciding factor in whether they become more ill or get better. This is largely due to the very significant difference that the presence or absence of vital nutrients has on the immune system.
Edouard d'Araille, lead researcher of the AVD research project, describes an 'Anti-Viral Diet' as: "a diet whose primary purpose is to counteract viral threats and to optimize the ability of our immune systems to fight off both viruses and viral diseases".
Download the Free 100-Page Sampler now. Learn more
'AVD' is a 3-Phase Research Project launched by The Academy of the Third Millennium (A3M). Phase 1 of this scientific inquiry is now complete and a summary of the findings are presented in the volume 'AVD: The Anti-Viral Diet' (2020/2021) available from this site. Information about the progress and purpose of Phases 2 and 3 of this ongoing A3M research program will be shared at the NEWS page on this website.
Provide Your Email Address to receive News Updates about on-going Scientific Research into Anti-Viral Dietary Ingredients and learn about How Nutritional Status affects Human Immunity to Lethal Viruses.
Provide your email address to receive your FREE 100-Page Sampler of AVD: The Anti-Viral Diet, including evidence from over 120 scientists in support of FIVE Anti-Viral Ingredients.